Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial

In this podcast, Dr. Valentin Fuster discusses the Target for NA trial, which compares biodegradable polymer stents to second-generation drug-eluting stents for coronary intervention. While the results showed the biodegradable stents were non-inferior in preventing target lesion failure, questions remain regarding their real-world performance and procedural handling in clinical practice.

Episode metadata supplied by the publisher feed · Published Feb 10, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial

0:00 12:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JACC This Week?

This episode is 12 minutes long.

When was this JACC This Week episode published?

This episode was published on February 10, 2025.

Can I download this JACC This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!